Literature DB >> 1555582

Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18.

S Taketani1, J Inazawa, Y Nakahashi, T Abe, R Tokunaga.   

Abstract

We have determined the structure of the human ferrochelatase gene after isolation and characterization of lambda phage clones mapping discrete regions of the cDNA. This gene was assigned to human chromosome 18 at region q21.3, by fluorescent in situ hybridization. The gene contains a total of 11 exons and has a minimum size of about 45 kb. The exon/intron boundary sequences conform to consensus acceptor (GTn) and donor (nAG) sequences, and the exons in the gene appear to encode functional protein domains. A major site of the transcription initiation, determined by S1 nuclease mapping, was assigned to an adenine base 89 bases upstream from the adenine base of the translation initiation ATG. The promoter region contains a potential binding site for Sp1, NF-E2 and erythroid-specific transcriptional factor GATA-1, but not a typical TATAA or CCAAT sequence. Analysis of primer extension showed that the transcription starts at the same position between hepatoma HepG2 and erythroleukemia K562 cell mRNA, thereby suggesting that there can be a single transcript in erythroid and non-erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555582     DOI: 10.1111/j.1432-1033.1992.tb16771.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  31 in total

1.  The diagnosis and management of erythropoietic protoporphyria.

Authors:  Manish Thapar; Herbert L Bonkovsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

2.  The low expression allele (IVS3-48C) of the ferrochelatase gene leads to low enzyme activity associated with erythropoietic protoporphyria.

Authors:  Tsuyoshi Tahara; Masayoshi Yamamoto; Reiko Akagi; Hideo Harigae; Shigeru Taketani
Journal:  Int J Hematol       Date:  2010-12-04       Impact factor: 2.490

3.  Genetic regulation of delta-aminolevulinate dehydratase during erythropoiesis.

Authors:  T R Bishop; M W Miller; J Beall; L I Zon; P Dierks
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

Review 4.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

Review 5.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

Review 6.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Gut       Date:  2007-03-14       Impact factor: 23.059

7.  Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.

Authors:  U B Rüfenacht; L Gouya; X Schneider-Yin; H Puy; B W Schäfer; R Aquaron; Y Nordmann; E I Minder; J C Deybach
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

8.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 9.  The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.

Authors:  S Taketani; H Fujita
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

10.  Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing.

Authors:  X Schneider-Yin; B W Schäfer; O Tönz; E I Minder
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.